A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth

BACKGROUND: Dose-dependent irreversible cardiac toxicity of doxorubicin (DOX) becomes a major obstacle for the clinical use. Nowadays much attention is being paid to combination therapy with DOX and antioxidant agents, which would improve the clinical efficacy by protecting from cardiotoxicity along...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Di, Xu, Qian, Wang, Ning, Yang, Yanting, Liu, Jiaqi, Yu, Guohua, Yang, Xin, Xu, Hui, Wang, Hongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091483/
https://www.ncbi.nlm.nih.gov/pubmed/30127606
http://dx.doi.org/10.2147/IJN.S170067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091483/
https://www.ncbi.nlm.nih.gov/pubmed/30127606
http://dx.doi.org/10.2147/IJN.S170067

Ejemplares similares